ECT Oekotoxikologie GmbH was founded as a privately owned, independent enterprise in 1993, and joined the SynTech Research Group in November 2021.
In compliance with Good Laboratory Practice (GLP), we perform standardised ecotoxicological tests in the laboratory as well as at semi-field and field level.
Find us at
ECT Oekotoxikologie GmbH
Böttgerstraße 2 – 14
65439 Flörsheim am Main
Phone: +49 6145 9564-0
Fax: +49 6145 9564-99
Cause-effect relations of key pollutants on the European rivers biodiversity (KEYBIOEFFECTS)
The overall objective of the research and training network KEYBIOEFFECTS was to provide young scientists with the skills and knowledge needed to assess the effects of pollution (with specific focus on key pollutants) on the biodiversity of European rivers and to transfer this knowledge to different stakeholder groups. Recognizing the importance of understanding cause-effect relationships […]
Models for assessing and forecasting the impact of environmental key pollutants on marine and freshwater ecosystems and biodiversity (MODELKEY)
The Water Framework Directive of the European Union requires a good ecological status of the European water bodies by 2015. One of the driving forces for an insufficient ecological status and reduced biodiversity of freshwater and marine ecosystems is chemical stress due to environmental pollutants. The project MODELKEY aims to contribute to the assessment, understanding […]
Novel methods for integrated risk assessment of cumulative stressors in Europe (NoMiracle)
NoMiracle (Novel Methods for Integrated Risk Assessment of CumuLative stressors in Europe) supports the development and improvement of methodologies, which describe and help to understand combined stressor effects to human health and the environment. In particular, the project studies the transfer of pollutants between different environmental compartments, including how these processes are influenced by natural […]
Environmental risk assessment of pharmaceuticals (ERAPharm)
The widespread detection of a large variety of pharmaceuticals in the environment has raised concern about the potential impact of these bioactive substances on the environment. The overall aim of ERAPharm was to advance existing knowledge and methods for the environmental risk assessment of pharmaceuticals. Within the three years of the project, the impact of […]